日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL)

Capivasertib (AZD5363) 是一种强效口服泛 AKT 抑制剂,用于治疗复发或难治性 B 细胞非霍奇金淋巴瘤患者的疗效和安全性 (CAPITAL)

Hodson, Daniel J; Shouse, Geoffrey; Shin, Ho-Jin; Salar, Antonio; Bobillo, Sabela; Ribrag, Vincent; Macpherson, Nicol A; Cordoba, Raul; Kim, Jin Seok; Guidez, Stephanie; Herrera, Alex F; Morschhauser, Franck; Colton, Dachelle; Izuzquiza, Macarena; Sambamurthy, Nisha; Munugalavadla, Veerendra; Vicente, Sergio; Gorgun, Gullu; Chen, Robert; Younes, Anas; Wang, Michael L

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

免疫化疗联合来那度胺治疗高危套细胞淋巴瘤伴可测量残留病灶的评估

Epstein-Peterson, Zachary D; Drill, Esther; Aypar, Umut; Batlevi, Connie Lee; Caron, Philip; Dogan, Ahmet; Drullinsky, Pamela; Gerecitano, John; Hamlin, Paul A; Ho, Caleb; Jacob, Allison; Joseph, Ashlee; Laraque, Leana; Matasar, Matthew J; Moskowitz, Alison J; Moskowitz, Craig H; Mullins, Chelsea; Owens, Colette; Salles, Gilles; Schöder, Heiko; Straus, David J; Younes, Anas; Zelenetz, Andrew D; Kumar, Anita

Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes

弥漫性大B细胞淋巴瘤累及骨骼:PET/CT疗效评估的实用性及良好的长期预后

Ghione, Paola; Ahsanuddin, Salma; Luttwak, Efrat; Varela, Sabela Bobillo; Nakajima, Reiko; Michaud, Laure; Gupta, Kanika; Navitski, Anastasia; Straus, David; Palomba, M Lia; Moskowitz, Alison; Noy, Ariela; Hamlin, Paul; Matasar, Matthew; Kumar, Anita; Falchi, Lorenzo; Yahalom, Joachim; Horwitz, Steven; Zelenetz, Andrew; Younes, Anas; Salles, Gilles; Schöder, Heiko; Joffe, Erel

Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

更正:免疫化疗联合来那度胺治疗高危套细胞淋巴瘤伴可测量残留病灶评估

Epstein-Peterson, Zachary D; Drill, Esther; Aypar, Umut; Batlevi, Connie Lee; Caron, Philip; Dogan, Ahmet; Drullinsky, Pamela; Gerecitano, John; Hamlin, Paul A; Ho, Caleb; Jacob, Allison; Joseph, Ashlee; Laraque, Leana; Matasar, Matthew J; Moskowitz, Alison J; Moskowitz, Craig H; Mullins, Chelsea; Owens, Colette; Salles, Gilles; Schöder, Heiko; Straus, David J; Younes, Anas; Zelenetz, Andrew D; Kumar, Anita

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

通过常规配对肿瘤和正常组织测序,加强对血液系统恶性肿瘤的临床评估。

Ptashkin, Ryan N; Ewalt, Mark D; Jayakumaran, Gowtham; Kiecka, Iwona; Bowman, Anita S; Yao, JinJuan; Casanova, Jacklyn; Lin, Yun-Te David; Petrova-Drus, Kseniya; Mohanty, Abhinita S; Bacares, Ruben; Benhamida, Jamal; Rana, Satshil; Razumova, Anna; Vanderbilt, Chad; Balakrishnan Rema, Anoop; Rijo, Ivelise; Son-Garcia, Julie; de Bruijn, Ino; Zhu, Menglei; Lachhander, Sean; Wang, Wei; Haque, Mohammad S; Seshan, Venkatraman E; Wang, Jiajing; Liu, Ying; Nafa, Khedoudja; Borsu, Laetitia; Zhang, Yanming; Aypar, Umut; Suehnholz, Sarah P; Chakravarty, Debyani; Park, Jae H; Abdel-Wahab, Omar; Mato, Anthony R; Xiao, Wenbin; Roshal, Mikhail; Yabe, Mariko; Batlevi, Connie Lee; Giralt, Sergio; Salles, Gilles; Rampal, Raajit; Tallman, Martin; Stein, Eytan M; Younes, Anas; Levine, Ross L; Perales, Miguel-Angel; van den Brink, Marcel R M; Dogan, Ahmet; Ladanyi, Marc; Berger, Michael F; Brannon, A Rose; Benayed, Ryma; Zehir, Ahmet; Arcila, Maria E

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

阿特珠单抗联合利妥昔单抗和CHOP方案治疗既往未接受治疗的弥漫性大B细胞淋巴瘤的安全性和有效性

Younes, Anas; Burke, John M; Cheson, Bruce D; Diefenbach, Catherine S; Ferrari, Silvia; Hahn, Uwe H; Hawkes, Eliza A; Khan, Cyrus; Lossos, Izidore S; Musuraca, Gerardo; Tani, Monica; Vitolo, Umberto; Yuen, Sam; Raval, Aparna; Shivhare, Mahesh; Nielsen, Tina G; Sellam, Gila; Sharman, Jeff P

Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting

临床环境中,中期正电子发射断层扫描(PET)结果呈阳性的患者继续接受ABVD方案治疗的预后

Zheng, Serena; Gupta, Kanika; Goyal, Piyush; Nakajima, Reiko; Michaud, Laure; Batlevi, Connie Lee; Hamlin, Paul A; Horwitz, Steven; Kumar, Anita; Matasar, Matthew J; Moskowitz, Alison J; Moskowitz, Craig H; Noy, Ariela; Palomba, M Lia; Straus, David J; Von Keudell, Gottfried; Falchi, Lorenzo; Yahalom, Joachim; Zelenetz, Andrew D; Younes, Anas; Salles, Gilles; Schöder, Heiko; Joffe, Erel

Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study

莫西替诺司他用于复发/难治性非霍奇金淋巴瘤(伴CREBBP或EP300突变)的分子靶向表观遗传治疗:一项开放标签II期研究

Qualls, David; Noy, Ariela; Straus, David; Matasar, Matthew; Moskowitz, Craig; Seshan, Venkatraman; Dogan, Ahmet; Salles, Gilles; Younes, Anas; Zelenetz, Andrew D; Batlevi, Connie Lee

A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials

比较 Lugano 2014 和 RECIL 2017 疗效评价标准在 III 期 GOYA 和 GALLIUM 试验中 NHL 患者预后预测性能

Kostakoglu, Lale; Martelli, Maurizio; Sehn, Laurie H; Davies, Andrew; Trněný, Marek; Herold, Michael; Vitolo, Umberto; Hiddemann, Wolfgang; Trotman, Judith; Knapp, Andrea; Mattiello, Federico; Nielsen, Tina G; Sahin, Deniz; Sellam, Gila; Ward, Carol; Younes, Anas

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

放射治疗的临床结果及早期滤泡性淋巴瘤的转化风险

Sha, Fushen; Okwali, Michelle; Alperovich, Anna; Caron, Philip C; Falchi, Lorenzo; Hamilton, Audrey; Hamlin, Paul A; Horwitz, Steven M; Joffe, Erel; Khan, Niloufer; Kumar, Anita; Matasar, Matthew J; Moskowitz, Alison J; Noy, Ariela; Owens, Colette; Palomba, Lia M; Rodriguez-Rivera, Ildefonso; Straus, David; von Keudell, Gottfried; Zelenetz, Andrew D; Yahalom, Joachim; Dogan, Ahmet; Schöder, Heiko; Seshan, Venkatraman E; Salles, Gilles; Younes, Anas; Batlevi, Connie L